New Market Research Report: Serbia Pharmaceuticals & Healthcare Report Q2 2014
While per capita expenditure on drugs is increasing steadily, Serbia's overall pharmaceutical market is still underdeveloped. Serbia frequently faces medicine shortages, as some retailers and pharmacists are unable to earn profits from the sale of these medicines, which is impacting patients. As the country continues its economic convergence with developed Europe, drug consumption is expected to rise. Meanwhile, financial inefficiencies within the health insurance system compel the National Health Insurance Institution (RZZO) to make frequent changes to coverage and pharmaceutical...
View full press release